New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment
Targeting PPP2R1A may improve responses even further according to laboratory studies?
PPP2R1A is an important predictive biomarker and possible treatment target for multiple cancer types, study found...
